NASDAQ:HELX
Franklin Genomic Advancements ETF News
$32.03
+0 (+0%)
At Close: May 17, 2024
Can Health Care Stocks Outperform Again In 2023?
06:09pm, Wednesday, 11'th Jan 2023
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
Why Now Could Be The Time To Consider Neuroscience Investments
04:45am, Saturday, 27'th Aug 2022
Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus to neurological health. Recent advances in genomic
Hop on HELX for Potential Biotech M&A
11:21am, Friday, 10'th Jun 2022
Blame inflation and rising interest rates, among other factors, but biotechnology mergers and acquisitions activity remains lethargic. That's despite a slump in biotech stocks dating back to early 202
Invest in the Fully Mapped Human Genome With This ETF
08:35pm, Monday, 18'th Apr 2022
Scientists have completed mapping the human genome. New research from the Telomere-to-Telomere (T2T) Consortium, a loose collaborative of about 100 scientists, shows that the team has completed a chal
ETF Deathwatch For August 2020
08:00am, Thursday, 10'th Sep 2020
Twenty-six exchange-traded products were added to the list, and 40 funds were removed, making August a busier month in terms of removals.
